Acceptability and Consumer Willingness to pay for a hypothetical HIV vaccine in Northern Brazil: A cross-sectional study and the implications.
Autor: | Nascimento, Gesiane Cavalcante, da Costa, Maria José Labis, Athie, Thannuse Silva, Silva, Juliana de Sales, Reis, Edna Afonso, Almeida-Brasil, Celline Cardoso, Godman, Brian, Godói, Isabella Piassi Dias |
---|---|
Předmět: |
VACCINATION
KRUSKAL-Wallis Test STATISTICS ANALYSIS of variance CONFIDENCE intervals ATTITUDE (Psychology) ETHICAL decision making CROSS-sectional method AIDS vaccines CONSUMER attitudes MANN Whitney U Test REGRESSION analysis INTERVIEWING DESCRIPTIVE statistics QUESTIONNAIRES RESEARCH funding STATISTICAL sampling DATA analysis software |
Zdroj: | Journal of HIV/AIDS & Social Services; 2022, Vol. 21 Issue 2, p145-166, 22p |
Abstrakt: | The Human Immunodeficiency Virus (HIV) is considered one of the greatest public health challenges given its impact on morbidity and mortality, and there is currently no vaccine available. The costs for any vaccine have to be weighed against current preventative measures as well as its impact in reducing future infections. This was the rationale behind conducting a willingness to pay (WTP) study to guide future funding decisions. A cross-sectional study was conducted involving residents of Northern Brazil regarding their WTP for a hypothetical vaccine against HIV with 70% effectiveness. 634 individuals were interviewed and 94% accepted to use this hypothetical vaccine. The WTP was US$47.54 (200.00BRL). We believe these findings can contribute to decision-making about pricing once a HIV vaccine becomes available in Brazil and in discussions with its acceptability. [ABSTRACT FROM AUTHOR] |
Databáze: | Complementary Index |
Externí odkaz: |